Business Wire

LTIMindtree Strengthens Relationship with Microsoft to Accelerate Microsoft Azure Adoption and Drive AI-Powered Transformation

19.11.2025 07:00:00 CET | Business Wire | Press Release

Share

LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has announced expansion of its global collaboration with Microsoft to accelerate Microsoft Azure adoption and drive AI-powered business transformation for enterprises. As a part of this collaboration, LTIMindtree will enable faster cloud adoption and unlock enhanced business value for joint customers through advanced AI solutions.

As a Global System Integrator (GSI) partner for Microsoft, LTIMindtree is deepening its commitment to enable global enterprises to maximize their cloud investments, Azure commits and achieve faster time-to-value. This collaboration underscores LTIMindtree’s ambition to deliver significant growth in Azure-related engagements, leveraging the strength of its 360° relationship with Microsoft across all the solution areas. It combines LTIMindtree’s industry expertise with Microsoft’s advanced AI capabilities, including Azure OpenAI in Microsoft Foundry, Microsoft 365 Copilot, and Fabric. Additionally, it will enable intelligent decision-making and automation across sectors, deliver secure and scalable cloud modernization through Azure migration programs, and accelerate Copilot adoption to boost workplace productivity and enhance customer engagement.

As a strategic partner, LTIMindtree has deployed the full Microsoft Security stack—Defender XDR, Sentinel, Intune, Windows Autopatch, and Entra ID—across multiple endpoints, ingesting comprehensive security data monthly for automated threat response. This security-first approach positions LTIMindtree as a model for secure hybrid and multi-cloud environments. Complementing this, LTIMindtree is leading the way in enterprise AI with internal adoption of Microsoft 365 Copilot. Guided by a governance-first rollout, Copilot is now embedded across workflows to enhance productivity and accelerate decision-making.

“Our collaboration with Microsoft is built on a shared vision of empowering enterprises to reimagine their future. By accelerating Azure adoption and embedding AI into every business process, we are helping customers move from pilots to productivity—unlocking innovation, resilience, and growth at scale,” said Venu Lambu, CEO & Managing Director, LTIMindtree.

“This collaboration with LTIMindtree underscores our joint commitment to supercharge innovation for organizations in the AI era. By adopting Microsoft AI across its own enterprise and applying those insights to help customers modernize and scale responsibly, LTIMindtree is setting the standard for transformation,” said Stephen Boyle, Vice President, Global System Integrators and Advisory Partners at Microsoft.

LTIMindtree plays a pivotal role in delivering key benefits to clients, including faster cloud adoption and optimized costs through Microsoft Azure Consumption Commitment (MAAC) agreement. In this valuable partnership, LTIMindtree has been recognized as a featured partner for Microsoft Fabric Real-Time Intelligence, reaffirming its leadership in data modernization and analytics. Additionally, LTIMindtree provides expert guidance in Microsoft Dynamics 365, enabling agile transformation and delivering end-to-end business application solutions for global enterprises.

About LTIMindtree:

LTIMindtree is a global technology consulting and digital solutions company that partners with enterprises across industries to reimagine business models, accelerate innovation, and drive AI-centric growth. Trusted by more than 700 clients worldwide, we use advanced technologies to enable operational excellence, elevated customer experiences, and long-term value creation. With a workforce of more than 86,000 talented and entrepreneurial professionals across over 40 countries, LTIMindtree — a Larsen & Toubro Group company — is dedicated to solving complex business challenges and delivering transformation at scale. For more information, please visit www.ltimindtree.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251118891146/en/

Contacts

Media Contact: Shambhavi Revandkar | Global Media Relations |
shambhavi.revandkar@ltimindtree.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye